Yumanity Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell YMTX and other ETFs, options, and stocks.

About YMTX

Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. 

CEO
Richard Peters
CEORichard Peters
Employees
40
Employees40
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
40
Employees40

YMTX Key Statistics

Market cap
17.31M
Market cap17.31M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
35.56K
Average volume35.56K
High today
$1.63
High today$1.63
Low today
$1.56
Low today$1.56
Open price
$1.58
Open price$1.58
Volume
24.98K
Volume24.98K
52 Week high
$10.72
52 Week high$10.72
52 Week low
$0.95
52 Week low$0.95

YMTX Earnings

-$1.13
-$0.75
-$0.38
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.